“Natural history” of complete cytoreductive surgery with hyperthermic intraperitoneal chemotherapy

Abstract Background Combining complete cytoreductive surgery (CCRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is a new approach allowing curatively intended treatment of multiple malignant peritoneal tumour seedings. This aggressive treatment is frequently followed by a complicated or a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of surgical oncology 2009-04, Vol.35 (4), p.434-438
Hauptverfasser: Elias, D, Di Pietrantonio, D, Boulet, T, Honore, C, Bonnet, S, Goere, D, Kohneh-Shahri, N, Raynard, B
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 438
container_issue 4
container_start_page 434
container_title European journal of surgical oncology
container_volume 35
creator Elias, D
Di Pietrantonio, D
Boulet, T
Honore, C
Bonnet, S
Goere, D
Kohneh-Shahri, N
Raynard, B
description Abstract Background Combining complete cytoreductive surgery (CCRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is a new approach allowing curatively intended treatment of multiple malignant peritoneal tumour seedings. This aggressive treatment is frequently followed by a complicated or an unusual postoperative course, that has yet to be described. Aim To describe the clinical and biological post-therapeutic course of patients treated with CCRS plus HIPEC, who were considered uncomplicated cases, and were discharged from hospital before the 15th postoperative day. Patients and methods Thirty-two patients were retrospectively selected on these criteria among 232 treated patients, most of whom had received intraperitoneal high-dose oxaliplatin and intravenous 5-fluorouracil. The daily postoperative clinical and biological parameters are presented in graphs using boxplots. Results Hyperthermia at 38 °C was the rule during the first postoperative week. The daily flow rate of the abdominal drains decreased progressively from 500 ml to 50 ml from day 1 to day 7. The flow rate of the nasogastric tube was high and close to 1000 ml/24 h until day 6. Resumption of digestive transit occurred between day 4 and day 6; it was always a diarrheic transit until day 12. Severe hypophosphoremia was observed at day 2 and day 3. White blood cells gradually decreased until day 12 to half the normal value, haemoglobin remained stable and the platelet count, which was low after surgery, continued to decrease progressively until day 3. Other data are presented. Conclusion These results, in this selected group of patients, allow a description of the “natural history” of CCRS plus HIPEC, which is not similar to classic uncomplicated postoperative courses following surgery. Knowledge of these “natural” changes may help avoid unnecessary explorations, and allow the early detection of postoperative complications.
doi_str_mv 10.1016/j.ejso.2008.02.009
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66986902</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0748798308000796</els_id><sourcerecordid>66986902</sourcerecordid><originalsourceid>FETCH-LOGICAL-c409t-27aac568b6cb5d1d6c91047e4eaf3023a8eb7f1786c8e2756ae4fe15363c059f3</originalsourceid><addsrcrecordid>eNp9kc-K1TAUxoM4OHeuvoAL6cpda9K0-QMiyKCjMIwLdR1y01Ob2jY1SUe6mwcZX26exJR7QZiFq0NOvu-D8_sQeklwQTBhb_oC-uCKEmNR4LLAWD5BO1LTMi9JzZ-iHeaVyLkU9BxdhNDjpKBcPkPnRFBe1ZTvUPtwd3-j4-L1kHU2ROfXh7s_mWsz48Z5gAiZWdMWmsVEewtZWPwP8Gv228Yu69YZfOzAj9Zkdopep7eNboIUZzoY3fap5_U5Omv1EODFae7R948fvl1-yq-_XH2-fH-dmwrLmJdca1MzcWDmUDekYUYSXHGoQLcUl1QLOPCWcMGMgJLXTEPVQjqZUYNr2dI9en3Mnb37tUCIarTBwDDoCdwSFGNSMJmS9qg8Co13IXho1eztqP2qCFYbXdWrja7a6Cpcqo3dHr06pS-HEZp_lhPOJHh7FEC68daCV8FYmAw01oOJqnH2__nvHtnNYCdr9PATVgi9W_yU6CmiQjKor1u_W71YpGq5ZPQvw6SlkA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66986902</pqid></control><display><type>article</type><title>“Natural history” of complete cytoreductive surgery with hyperthermic intraperitoneal chemotherapy</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Elias, D ; Di Pietrantonio, D ; Boulet, T ; Honore, C ; Bonnet, S ; Goere, D ; Kohneh-Shahri, N ; Raynard, B</creator><creatorcontrib>Elias, D ; Di Pietrantonio, D ; Boulet, T ; Honore, C ; Bonnet, S ; Goere, D ; Kohneh-Shahri, N ; Raynard, B</creatorcontrib><description>Abstract Background Combining complete cytoreductive surgery (CCRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is a new approach allowing curatively intended treatment of multiple malignant peritoneal tumour seedings. This aggressive treatment is frequently followed by a complicated or an unusual postoperative course, that has yet to be described. Aim To describe the clinical and biological post-therapeutic course of patients treated with CCRS plus HIPEC, who were considered uncomplicated cases, and were discharged from hospital before the 15th postoperative day. Patients and methods Thirty-two patients were retrospectively selected on these criteria among 232 treated patients, most of whom had received intraperitoneal high-dose oxaliplatin and intravenous 5-fluorouracil. The daily postoperative clinical and biological parameters are presented in graphs using boxplots. Results Hyperthermia at 38 °C was the rule during the first postoperative week. The daily flow rate of the abdominal drains decreased progressively from 500 ml to 50 ml from day 1 to day 7. The flow rate of the nasogastric tube was high and close to 1000 ml/24 h until day 6. Resumption of digestive transit occurred between day 4 and day 6; it was always a diarrheic transit until day 12. Severe hypophosphoremia was observed at day 2 and day 3. White blood cells gradually decreased until day 12 to half the normal value, haemoglobin remained stable and the platelet count, which was low after surgery, continued to decrease progressively until day 3. Other data are presented. Conclusion These results, in this selected group of patients, allow a description of the “natural history” of CCRS plus HIPEC, which is not similar to classic uncomplicated postoperative courses following surgery. Knowledge of these “natural” changes may help avoid unnecessary explorations, and allow the early detection of postoperative complications.</description><identifier>ISSN: 0748-7983</identifier><identifier>EISSN: 1532-2157</identifier><identifier>DOI: 10.1016/j.ejso.2008.02.009</identifier><identifier>PMID: 18374537</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Adult ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Camptothecin - administration &amp; dosage ; Camptothecin - analogs &amp; derivatives ; Disease Progression ; Drainage ; Female ; Fluorouracil - administration &amp; dosage ; Hematology, Oncology and Palliative Medicine ; Humans ; Hyperthermia, Induced - methods ; Intraperitoneal chemo-hyperthermia ; Male ; Middle Aged ; Mitomycin - administration &amp; dosage ; Morbidity ; Natural history ; Neoplasm Seeding ; Neoplasms, Multiple Primary - therapy ; Organoplatinum Compounds - administration &amp; dosage ; Peritoneal malignancy ; Peritoneal Neoplasms - therapy ; Postoperative Care - methods ; Postoperative course ; Retrospective Studies ; Surgery ; Treatment Outcome</subject><ispartof>European journal of surgical oncology, 2009-04, Vol.35 (4), p.434-438</ispartof><rights>Elsevier Ltd</rights><rights>2008 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c409t-27aac568b6cb5d1d6c91047e4eaf3023a8eb7f1786c8e2756ae4fe15363c059f3</citedby><cites>FETCH-LOGICAL-c409t-27aac568b6cb5d1d6c91047e4eaf3023a8eb7f1786c8e2756ae4fe15363c059f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejso.2008.02.009$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18374537$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Elias, D</creatorcontrib><creatorcontrib>Di Pietrantonio, D</creatorcontrib><creatorcontrib>Boulet, T</creatorcontrib><creatorcontrib>Honore, C</creatorcontrib><creatorcontrib>Bonnet, S</creatorcontrib><creatorcontrib>Goere, D</creatorcontrib><creatorcontrib>Kohneh-Shahri, N</creatorcontrib><creatorcontrib>Raynard, B</creatorcontrib><title>“Natural history” of complete cytoreductive surgery with hyperthermic intraperitoneal chemotherapy</title><title>European journal of surgical oncology</title><addtitle>Eur J Surg Oncol</addtitle><description>Abstract Background Combining complete cytoreductive surgery (CCRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is a new approach allowing curatively intended treatment of multiple malignant peritoneal tumour seedings. This aggressive treatment is frequently followed by a complicated or an unusual postoperative course, that has yet to be described. Aim To describe the clinical and biological post-therapeutic course of patients treated with CCRS plus HIPEC, who were considered uncomplicated cases, and were discharged from hospital before the 15th postoperative day. Patients and methods Thirty-two patients were retrospectively selected on these criteria among 232 treated patients, most of whom had received intraperitoneal high-dose oxaliplatin and intravenous 5-fluorouracil. The daily postoperative clinical and biological parameters are presented in graphs using boxplots. Results Hyperthermia at 38 °C was the rule during the first postoperative week. The daily flow rate of the abdominal drains decreased progressively from 500 ml to 50 ml from day 1 to day 7. The flow rate of the nasogastric tube was high and close to 1000 ml/24 h until day 6. Resumption of digestive transit occurred between day 4 and day 6; it was always a diarrheic transit until day 12. Severe hypophosphoremia was observed at day 2 and day 3. White blood cells gradually decreased until day 12 to half the normal value, haemoglobin remained stable and the platelet count, which was low after surgery, continued to decrease progressively until day 3. Other data are presented. Conclusion These results, in this selected group of patients, allow a description of the “natural history” of CCRS plus HIPEC, which is not similar to classic uncomplicated postoperative courses following surgery. Knowledge of these “natural” changes may help avoid unnecessary explorations, and allow the early detection of postoperative complications.</description><subject>Adult</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Camptothecin - administration &amp; dosage</subject><subject>Camptothecin - analogs &amp; derivatives</subject><subject>Disease Progression</subject><subject>Drainage</subject><subject>Female</subject><subject>Fluorouracil - administration &amp; dosage</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Hyperthermia, Induced - methods</subject><subject>Intraperitoneal chemo-hyperthermia</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mitomycin - administration &amp; dosage</subject><subject>Morbidity</subject><subject>Natural history</subject><subject>Neoplasm Seeding</subject><subject>Neoplasms, Multiple Primary - therapy</subject><subject>Organoplatinum Compounds - administration &amp; dosage</subject><subject>Peritoneal malignancy</subject><subject>Peritoneal Neoplasms - therapy</subject><subject>Postoperative Care - methods</subject><subject>Postoperative course</subject><subject>Retrospective Studies</subject><subject>Surgery</subject><subject>Treatment Outcome</subject><issn>0748-7983</issn><issn>1532-2157</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc-K1TAUxoM4OHeuvoAL6cpda9K0-QMiyKCjMIwLdR1y01Ob2jY1SUe6mwcZX26exJR7QZiFq0NOvu-D8_sQeklwQTBhb_oC-uCKEmNR4LLAWD5BO1LTMi9JzZ-iHeaVyLkU9BxdhNDjpKBcPkPnRFBe1ZTvUPtwd3-j4-L1kHU2ROfXh7s_mWsz48Z5gAiZWdMWmsVEewtZWPwP8Gv228Yu69YZfOzAj9Zkdopep7eNboIUZzoY3fap5_U5Omv1EODFae7R948fvl1-yq-_XH2-fH-dmwrLmJdca1MzcWDmUDekYUYSXHGoQLcUl1QLOPCWcMGMgJLXTEPVQjqZUYNr2dI9en3Mnb37tUCIarTBwDDoCdwSFGNSMJmS9qg8Co13IXho1eztqP2qCFYbXdWrja7a6Cpcqo3dHr06pS-HEZp_lhPOJHh7FEC68daCV8FYmAw01oOJqnH2__nvHtnNYCdr9PATVgi9W_yU6CmiQjKor1u_W71YpGq5ZPQvw6SlkA</recordid><startdate>20090401</startdate><enddate>20090401</enddate><creator>Elias, D</creator><creator>Di Pietrantonio, D</creator><creator>Boulet, T</creator><creator>Honore, C</creator><creator>Bonnet, S</creator><creator>Goere, D</creator><creator>Kohneh-Shahri, N</creator><creator>Raynard, B</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20090401</creationdate><title>“Natural history” of complete cytoreductive surgery with hyperthermic intraperitoneal chemotherapy</title><author>Elias, D ; Di Pietrantonio, D ; Boulet, T ; Honore, C ; Bonnet, S ; Goere, D ; Kohneh-Shahri, N ; Raynard, B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c409t-27aac568b6cb5d1d6c91047e4eaf3023a8eb7f1786c8e2756ae4fe15363c059f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adult</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Camptothecin - administration &amp; dosage</topic><topic>Camptothecin - analogs &amp; derivatives</topic><topic>Disease Progression</topic><topic>Drainage</topic><topic>Female</topic><topic>Fluorouracil - administration &amp; dosage</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Hyperthermia, Induced - methods</topic><topic>Intraperitoneal chemo-hyperthermia</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mitomycin - administration &amp; dosage</topic><topic>Morbidity</topic><topic>Natural history</topic><topic>Neoplasm Seeding</topic><topic>Neoplasms, Multiple Primary - therapy</topic><topic>Organoplatinum Compounds - administration &amp; dosage</topic><topic>Peritoneal malignancy</topic><topic>Peritoneal Neoplasms - therapy</topic><topic>Postoperative Care - methods</topic><topic>Postoperative course</topic><topic>Retrospective Studies</topic><topic>Surgery</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Elias, D</creatorcontrib><creatorcontrib>Di Pietrantonio, D</creatorcontrib><creatorcontrib>Boulet, T</creatorcontrib><creatorcontrib>Honore, C</creatorcontrib><creatorcontrib>Bonnet, S</creatorcontrib><creatorcontrib>Goere, D</creatorcontrib><creatorcontrib>Kohneh-Shahri, N</creatorcontrib><creatorcontrib>Raynard, B</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Elias, D</au><au>Di Pietrantonio, D</au><au>Boulet, T</au><au>Honore, C</au><au>Bonnet, S</au><au>Goere, D</au><au>Kohneh-Shahri, N</au><au>Raynard, B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>“Natural history” of complete cytoreductive surgery with hyperthermic intraperitoneal chemotherapy</atitle><jtitle>European journal of surgical oncology</jtitle><addtitle>Eur J Surg Oncol</addtitle><date>2009-04-01</date><risdate>2009</risdate><volume>35</volume><issue>4</issue><spage>434</spage><epage>438</epage><pages>434-438</pages><issn>0748-7983</issn><eissn>1532-2157</eissn><abstract>Abstract Background Combining complete cytoreductive surgery (CCRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is a new approach allowing curatively intended treatment of multiple malignant peritoneal tumour seedings. This aggressive treatment is frequently followed by a complicated or an unusual postoperative course, that has yet to be described. Aim To describe the clinical and biological post-therapeutic course of patients treated with CCRS plus HIPEC, who were considered uncomplicated cases, and were discharged from hospital before the 15th postoperative day. Patients and methods Thirty-two patients were retrospectively selected on these criteria among 232 treated patients, most of whom had received intraperitoneal high-dose oxaliplatin and intravenous 5-fluorouracil. The daily postoperative clinical and biological parameters are presented in graphs using boxplots. Results Hyperthermia at 38 °C was the rule during the first postoperative week. The daily flow rate of the abdominal drains decreased progressively from 500 ml to 50 ml from day 1 to day 7. The flow rate of the nasogastric tube was high and close to 1000 ml/24 h until day 6. Resumption of digestive transit occurred between day 4 and day 6; it was always a diarrheic transit until day 12. Severe hypophosphoremia was observed at day 2 and day 3. White blood cells gradually decreased until day 12 to half the normal value, haemoglobin remained stable and the platelet count, which was low after surgery, continued to decrease progressively until day 3. Other data are presented. Conclusion These results, in this selected group of patients, allow a description of the “natural history” of CCRS plus HIPEC, which is not similar to classic uncomplicated postoperative courses following surgery. Knowledge of these “natural” changes may help avoid unnecessary explorations, and allow the early detection of postoperative complications.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>18374537</pmid><doi>10.1016/j.ejso.2008.02.009</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0748-7983
ispartof European journal of surgical oncology, 2009-04, Vol.35 (4), p.434-438
issn 0748-7983
1532-2157
language eng
recordid cdi_proquest_miscellaneous_66986902
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adult
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Camptothecin - administration & dosage
Camptothecin - analogs & derivatives
Disease Progression
Drainage
Female
Fluorouracil - administration & dosage
Hematology, Oncology and Palliative Medicine
Humans
Hyperthermia, Induced - methods
Intraperitoneal chemo-hyperthermia
Male
Middle Aged
Mitomycin - administration & dosage
Morbidity
Natural history
Neoplasm Seeding
Neoplasms, Multiple Primary - therapy
Organoplatinum Compounds - administration & dosage
Peritoneal malignancy
Peritoneal Neoplasms - therapy
Postoperative Care - methods
Postoperative course
Retrospective Studies
Surgery
Treatment Outcome
title “Natural history” of complete cytoreductive surgery with hyperthermic intraperitoneal chemotherapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T04%3A29%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=%E2%80%9CNatural%20history%E2%80%9D%20of%20complete%20cytoreductive%20surgery%20with%20hyperthermic%20intraperitoneal%20chemotherapy&rft.jtitle=European%20journal%20of%20surgical%20oncology&rft.au=Elias,%20D&rft.date=2009-04-01&rft.volume=35&rft.issue=4&rft.spage=434&rft.epage=438&rft.pages=434-438&rft.issn=0748-7983&rft.eissn=1532-2157&rft_id=info:doi/10.1016/j.ejso.2008.02.009&rft_dat=%3Cproquest_cross%3E66986902%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=66986902&rft_id=info:pmid/18374537&rft_els_id=S0748798308000796&rfr_iscdi=true